Author

Diana V. Morales

Columbia University Irving Medical CenterORCID 0009-0005-8590-861XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Aaron Timothy GriffiniD· 1 shared Agnès BassevilleiD· 1 shared Aleksandar ObradovićiD· 1 shared Amy W. KuiD· 1 shared Andrea CalifanoiD· 1 shared Cheng–Chia WuiD· 1 shared Christian SimmonsiD· 1 shared Christopher B. DamociiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Aaron Timothy GriffinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyDrug Resistance UpdatesPeer-reviewedOct 5, 2025

Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma

Maryam Safari, Luigi Scotto, Agnès Basseville…·Susan Elaine Bates

This paper shows that combining HDAC and eIF4A inhibitors effectively treats pancreatic cancer by inducing epigenetic reprogramming and metabolic stress in preclinical models.

6 citations

mousebulk RNA-seq

𝕏 PostBluesky

Systems BiologybioRxivPreprintMar 17, 2024

Elucidation and Pharmacologic Targeting of Master Regulator Dependencies in Coexisting Diffuse Midline Glioma Subpopulations

Ester Calvo Fernández, Lorenzo Tomassoni, Xu Zhang…·Jovana Pavisic

The paper identifies master regulator dependencies in coexisting diffuse midline glioma subpopulations and shows that combination therapy targeting these regulators improves survival in vivo.

4 citations

humanscRNA-seq

𝕏 PostBluesky